ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,067.70
0.92%
US Tech 100
20,840.40
1.32%
Dow Jones
44,850.35
0.31%
Brent Oil
76.61
0.45%
Bitcoin
101,083.41
-0.96%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NeuroBo Pharmaceuticals Inc (NRBO) Quote

NeuroBo Pharmaceuticals Inc

NeuroBo Pharmaceuticals Inc (NRBO)

NASDAQ
2.36
0.00
(0.00%)
At close: January 28 4:00PM
Delayed by 15 minutes
2.36
0.00
( 0.00% )
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.36
Bid
2.31
Ask
2.49
Volume
-
0.00 Day's Range 0.00
2.08 52 Week Range 6.7499
Market Cap
20.334M
Previous Close
2.36
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
10,439
Shares Outstanding
8,616,010
Dividend Yield
-
PE Ratio
-1.37
Earnings Per Share (EPS)
-1.45
Revenue
-
Net Profit
-12.47M

About NeuroBo Pharmaceuticals Inc

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is ... NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.neurobopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
NeuroBo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NRBO. The last closing price for NeuroBo Pharmaceuticals was $2.36. Over the last year, NeuroBo Pharmaceuticals shares have traded in a share price range of $ 2.08 to $ 6.7499.

NeuroBo Pharmaceuticals currently has 8,616,010 shares outstanding. The market capitalization of NeuroBo Pharmaceuticals is $20.33 million. NeuroBo Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.37.

Ask ADVFN Intelligence (AI)

NRBO Latest News

More News

Form 8-K - Current report

January 10 2025
Edgar (US Regulatory)

Form 8-K - Current report

December 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

December 02 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 18 2024
Edgar (US Regulatory)

NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases

NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases PR...

November 18 2024
PR Newswire (US)

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor...

November 15 2024
GlobeNewswire Inc.

NeuroBo Pharmaceuticals to Participate in Investor Conferences in November

NeuroBo Pharmaceuticals to Participate in Investor Conferences in November PR Newswire CAMBRIDGE, Mass., Nov. 13, 2024 CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals...

November 13 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 07 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1002.362.362.3600CS
4002.362.362.3600CS
12-0.38-13.86861313872.742.98812.18104392.51043449CS
26-1.79-43.13253012054.154.3632.08275153.1434764CS
52-0.74-23.87096774193.16.74992.083638525.29487335CS
156-237.64-99.0166666667240510.82.0878012743.59762279CS
260-1963.24-99.87993487991965.672002.08676955309.89921066CS

NRBO - Frequently Asked Questions (FAQ)

What is the current NeuroBo Pharmaceuticals share price?
The current share price of NeuroBo Pharmaceuticals is $ 2.36
How many NeuroBo Pharmaceuticals shares are in issue?
NeuroBo Pharmaceuticals has 8,616,010 shares in issue
What is the market cap of NeuroBo Pharmaceuticals?
The market capitalisation of NeuroBo Pharmaceuticals is USD 20.33M
What is the 1 year trading range for NeuroBo Pharmaceuticals share price?
NeuroBo Pharmaceuticals has traded in the range of $ 2.08 to $ 6.7499 during the past year
What is the PE ratio of NeuroBo Pharmaceuticals?
The price to earnings ratio of NeuroBo Pharmaceuticals is -1.37
What is the reporting currency for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals reports financial results in USD
What is the latest annual profit for NeuroBo Pharmaceuticals?
The latest annual profit of NeuroBo Pharmaceuticals is USD -12.47M
What is the registered address of NeuroBo Pharmaceuticals?
The registered address for NeuroBo Pharmaceuticals is 108 WEST 13TH ST, WILMINGTON, DELAWARE, 19801
What is the NeuroBo Pharmaceuticals website address?
The website address for NeuroBo Pharmaceuticals is www.neurobopharma.com
Which industry sector does NeuroBo Pharmaceuticals operate in?
NeuroBo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SXTP60 Degrees Pharmaceuticals Inc
$ 1.11
(44.01%)
5.03M
LGCLLucas GC Ltd
$ 0.7501
(31.14%)
690.05k
PWMPrestige Wealth Inc
$ 1.38
(28.97%)
358.4k
SXTCChina SXT Pharmaceuticals Inc
$ 0.5499
(23.02%)
328.94k
FFIEFaraday Future Intelligent Electric Inc
$ 1.66
(22.96%)
2.09M
WBUYWeBuy Global Ltd
$ 0.0857
(-30.61%)
3.26M
MANHManhattan Associates Inc
$ 222.50
(-24.60%)
72.24k
HAOHaoxi Health Technology Ltd
$ 2.80
(-24.32%)
1.7M
EYENEyenovia Inc
$ 0.044
(-22.81%)
5.15M
MGOLMGO Global Inc
$ 0.130101
(-21.77%)
12.84M
BHATBlue Hat Interactive Entertainment Technology
$ 0.0469
(-18.86%)
29.95M
MGOLMGO Global Inc
$ 0.130101
(-21.77%)
12.84M
RIMEAlgorhythm Holdings Inc
$ 0.0292
(-5.50%)
11.76M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.4903
(6.56%)
9.13M
NVDANVIDIA Corporation
$ 127.761
(-0.95%)
7.38M

Discussion

View Full Feed
NYBob NYBob 5 minutes ago
NEWS RELEASE: Pelangio Exploration Commences Exploration Follow Up Testing of
Targets from UAV Magnetics Survey at Obuasi, Ghana
TORONTO, Ontario (January 27th, 2025) –

https://pelangio.com/site/assets/files/5638/2025_01_27_pelangio_obuasi_planned_pitting_program_29117
PGXPF
Zorax Zorax 6 minutes ago
I have to submit they strongly believe they can't lose no matter what... cause scrotum court.
northam43 northam43 7 minutes ago
Report #2 January 2025 SPX Cycles

https://investorshub.advfn.com/uimage/uploads/2025/1/28/xltmr2_Completed_Cycles.PNG
newlevel87 newlevel87 7 minutes ago
lol this board is amusing I love it.... $$$$ only a few that see the big money coming.  I can wait no rush for me. Action has been same for last few weeks, some days volume some days not.
TKMO
Dapper1 Dapper1 8 minutes ago
HMBL longs have waited years and deserve another TSNP type moon ride...NFA,LG!
HMBL
Zorax Zorax 8 minutes ago
Oh, I'm sure the red states will be taken care of. If not up front, then behind closed doors on the house/senate floor where dems cant vote anything down depending on the bill vote setup.
delerious1 delerious1 8 minutes ago
Doing another deep dive ....btw we closed flat for the day but managed some good volume and further solidifying the base. Today I learned that Pink sheet CEOs are the most honest and trustworthy people on Earth. They are incapable of exaggeration, evasiveness or the stating of falsehoods. And I lear
NBRI
money6870 money6870 8 minutes ago
Hopefully news incoming.
APRU
jay_tee jay_tee 8 minutes ago
Can't be out of the blue. They have to file something.  Not filling is the main reason why the SEC places a company on the EM.  style="font-size: 1em"Double check that... but hey I can be wrong
RNVA
shoondale shoondale 9 minutes ago
True blue Dr. Drew and Albanna... https://www.facebook.com/varneyco/videos/amro-albanna-and-dr-drew-on-aditx-covid-testing-device/1595447620655957/ https://www.facebook.com/varneyco/videos/amro-albanna-and-dr-drew-on-aditx-covid-testing-device/1595447620655957/ This keeps getting better and better
ADTX
gp22 gp22 9 minutes ago
$STSS @ .40s: Offering today @ $1.40 cratered stock. Excellent company was over $2.00 last week. Unusual op to make some easy free money.
$STSS already coming off the lows.
Likely comfortably back over $1.00 by weeks end.
STSS
Mr. Dragon Mr. Dragon 9 minutes ago
Traitor53 nowhere to be found. I wonder how many got sucked into bagholding from his pumper posts "Maximun point of financial blah....blah." Come on Traitor53.....make an appearance and tell us all the new point where unsuspecting victims should enter this roach motel.
DPLS
JSmith5 JSmith5 10 minutes ago
That is how you want GOV to work?

She bought the bonds. There is nothing wrong with that.

Nats
FNMA
LakeshoreLeo1953 LakeshoreLeo1953 10 minutes ago
While every situation is different…
Three main categories of taxation
(as pertain to stocks)
1. Short Term
2. Long Term
3. Exempt

Throw in LIFO/FIFO and different calculations of basis and

Either you surrender the fees to keep yoursel
AVXL
gp22 gp22 10 minutes ago
$STSS @ .40s: Offering today @ $1.40 cratered stock. Excellent company was over $2.00 last week. Unusual op to make some easy free money.
$STSS already coming off the lows.
Likely comfortably back over $1.00 by weeks end.
STSS
Clark6290 Clark6290 10 minutes ago
They approved him based on qualifications, not skin color or ethnic background to meet a quota. All about qualifications and not selection by DEI
FNMA
SSKILLZ1 SSKILLZ1 10 minutes ago
Pick 4 Contest #21 Trades
[pre]
Date Alias Stock Sold % Gain/Loss Stock Bought # Of Shares PP
1/6/2025 WYOBUFORD $$ 0.00% NVEC 11.5540 $86.55
1/10/2025 SSKILLZ1 $$ 0.00% INBK 31.0366 $32.22
1/10/2025 HAWKEYE_TT
AES CEAD CMI
gp22 gp22 11 minutes ago
$STSS @ .40s: Offering today @ $1.40 cratered stock. Excellent company. Unusual op to make some easy free money.
$STSS already coming off the lows.
Likely comfortably back over $1.00 by weeks end.
STSS
diggitydoodle diggitydoodle 11 minutes ago
I've been in tickers that have gone from the EM and back, right outta the blue. Without any info or leaks.
Made good money on one.
No one knows what's going on here
Some think they do, but...not!
I don't expect anything.
RNVA!!$$?????????????????
RNVA
wingshooterr wingshooterr 12 minutes ago
Update on the company website
https://coincitadel.net/
Now STFU!! and go read the recent news
CCTL
waterchaser waterchaser 12 minutes ago
From IHUB Admin:
Early heads up.. the last and most complex part of migrating our systems to a cloud-based infrastructure will start on Saturday morning. There will be extended periods when the site is down completely and inevitably other times when various parts of the site are not working p
HIRU
MightyX MightyX 12 minutes ago
I bet yall do
TPTW
Lime Time Lime Time 12 minutes ago
Many catalysts can come here. The OS is still low within my liking. Cancel RS news will send it up 1000% from here. I guess we see what happens.
GXXM
TenKay TenKay 13 minutes ago
“They were out there today again“

They were? Nothing on the news. Got a link?

That video was from 2 years ago…even the tweet says 2 years ago…

January 2023 was when that protest occurred.

Might need to up your DD game a little…
HMBL

Your Recent History

NASDAQ
NRBO
NeuroBo Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads